Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
OPAL logo

The Oxford Pain, Activity and Lifestyle (OPAL) study is now open to recruitment.

The OPAL cohort study, which is part of the BOOST (Better Outcomes for Older people with Spinal Trouble) programme of work, is studying health outcomes in older adults. The pilot site, a GP practice in Birmingham, opened on 4 October 2016 and further sites will be opened shortly.

OPAL is a five year survey study which looks at how people's health and physical activity change over time. Data will be collected from 4,000 community dwelling adults, aged 65 and over, from 40 GP practices across England. The information collected will help the study team to understand how a person's health affects their mobility as they age, and provide insight into improving the management of health in older adults.

The aim is to develop a prognostic tool using the study data that will help older people, GPs and other health professionals identify when low back pain is a risk factor for disability, functional limitation and loss of mobility, and when it should be prioritised as a treatment target.

More information can be found on the study website www.opalstudy.org.uk

Similar stories

SCIENCE spreads across the world

Oxford Trauma are pleased to open their first overseas site for the SCIENCE study.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

PRoCuRe opens to recruitment

The Partial Rotator Cuff Tear Repair Trial (PRoCuRe) is open to recruitment at Oxford University Hospitals NHS Foundation Trust after achieving OCTRU Green Light approval!

IMP-MEL Trial given Green Light to open

OCTRU have now given Green Light approval for IMP MEL to open. This is a phase 1 first-in-human dose finding/randomised phase 2 study of IMM60 and pembrolizumab in advanced melanoma and NSCLC.

WISE opens to recruitment

The WISE Study - Wrist Injury Strengthening Exercise: a randomised multicentre feasibility study of resistance exercise versus usual care for optimising function after distal radius fracture in adults aged 50 years or over has now received OCTRU Green Light approval and has opened to recruitment.